Cargando…
Bone Marrow Mastocytosis: A Diagnostic Challenge
Bone marrow mastocytosis (BMM) represents a provisional, indolent subvariant of systemic mastocytosis (SM). Utilizing WHO criteria, BMM requires bone marrow (BM) involvement and the absence of mastocytosis skin lesions. BMM is characterized by male sex prevalence, a slight increase of serum tryptase...
Autores principales: | Zanotti, Roberta, Tanasi, Ilaria, Bernardelli, Andrea, Orsolini, Giovanni, Bonadonna, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037514/ https://www.ncbi.nlm.nih.gov/pubmed/33915965 http://dx.doi.org/10.3390/jcm10071420 |
Ejemplares similares
-
Systemic Mastocytosis: Multidisciplinary Approach
por: Zanotti, Roberta, et al.
Publicado: (2021) -
A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network
por: Zanotti, Roberta, et al.
Publicado: (2021) -
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis
por: Bonifacio, Massimiliano, et al.
Publicado: (2017) -
Non-steroidal anti-inflammatory drug-induced anaphylaxis infrequent in 388 patients with mastocytosis: A two-center retrospective cohort study
por: Bonadonna, Patrizia, et al.
Publicado: (2022) -
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis
por: Mannelli, Francesco, et al.
Publicado: (2023)